Sunkaru Touray 1,2, Michael C Newstein 1,2, Justin K Lui 1,2, Maureen Harris 2 and Kim Knox 2

Similar documents
Evaluation of the Oxoid Xpect Legionella test kit for Detection of Legionella

Community acquired pneumonia due to Legionella pneumophila in a tertiary care hospital

Community-Acquired Pneumonia OBSOLETE 2

JCP Online First, published on June 17, 2013 as /jclinpath Original article

Supplementary Online Content

Antimicrobial Stewardship in Community Acquired Pneumonia

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP

Downloaded from:

Current and Emerging Legionella Diagnostics

Supplementary appendix

Legionnaire s disease is a febrile illness with pneumonia. The Radiologic Manifestations of Legionnaire s Disease*

Late diagnosis of influenza in adult patients during a seasonal outbreak

Epidemiology and Etiology of Community-Acquired Pneumonia 761 Lionel A. Mandell

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

Supplementary Appendix

ORIGINAL ARTICLE. Abstract. Introduction. Hiroki Yamakuchi 1, Yohei Hamada 2, Tosiharu Urakami 2 and Yosuke Aoki 2,3

Repeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia

Pneumonia Community-Acquired Healthcare-Associated

HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY

Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No

Sensitivity of three serum antibody tests in a large outbreak of Legionnaires disease in the Netherlands

Microbiology Laboratory Directors, Infection Preventionists, Primary Care Providers, Emergency Department Directors, Infectious Disease Physicians

Community Acquired Pneumonia

COPD exacerbation. Dr. med. Frank Rassouli

Pneumonia Severity Scores:

Influenza-Associated Pediatric Deaths Case Report Form

Aetiology and resistance pattern of communityacquired pneumonia in León, Nicaragua

Study objective: To investigate the clinical presentation of community-acquired Chlamydia

Making the Right Call With. Pneumonia. Community-acquired pneumonia (CAP) is a. Community-Acquired. What exactly is CAP?

UPDATE IN HOSPITAL MEDICINE

Pneumonia and influenza combined are the fifth leading

Sporadic and epidemic community legionellosis: two faces of the same illness

HIV AND LUNG HEALTH. Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital

JAC Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections

Community-acquired pneumonia (CAP)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

pneumonia 2015;6:48 56

Open Access RESEARCH ARTICLE. Research article. BioMed Central

Outcomes: Initially, our primary definitions of pneumonia was severe pneumonia, where the subject was hospitalized

Pseudomonas aeruginosa

APPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10

Guidelines. 14 Nov Marc Bonten

point-of-care test (POCT) Definition: an analytical or diagnostic test undertaken in a setting distinct from a normal hospital or non-hospital

Measles: United States, January 1 through June 10, 2011

Copyright by the Cambridge University Press

Legionnaire s Disease: Overview and Treatment

Legionellosis Water Management and Investigation Case Study

PubH 7405: REGRESSION ANALYSIS. Propensity Score

Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults

BIOSTATISTICAL METHODS

Mædica - a Journal of Clinical Medicine

Can we truly rely on the urinary antigen test for the diagnosis? Legionella case report

Patient information: Pneumonia in adults (Beyond the Basics)

KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA

Unit II Problem 2 Microbiology Lab: Pneumonia

Health Board Logo. Post SARS Outbreak Surveillance. Report of possible or probable cases (Form version 1) February 11 th 2004

A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU*

How do we define pneumonia?

Chapter 22. Pulmonary Infections

Value of an economic analysis on diagnostic tests conducted for the Pneumonia NICE Clinical Guideline

Diagnosis of Ventilator- Associated Pneumonia: Where are we now?

POLICY FOR TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS

IMMUVIEW L. PNEUMOPHILA AND L. LONGBEACHAE URINARY ANTIGEN TEST. SSI Diagnostica

Portugal s Legionella outbreak - What can we learn with it?

Simultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR (1167)

Session Guidelines. This is a 15 minute webinar session for CNC physicians and staff

Joan Puig-Barberà 1*, Elena Burtseva 2, Hongjie Yu 3, Benjamin J. Cowling 4, Selim Badur 5, Jan Kyncl 6, Anna Sominina 7 and on behalf of the GIHSN

Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty

Setting The setting was secondary care. The economic study was carried out in the USA.

Detection of Chlamydia pneumonia and Mycoplasma pneumonia in hospitalised children with community acquired pneumonia

Upper...and Lower Respiratory Tract Infections

JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 1998, p Vol. 36, No. 9. Copyright 1998, American Society for Microbiology. All Rights Reserved.

Research Article The Diagnostic Value of Serum C-Reactive Protein for Identifying Pneumonia in Hospitalized Patients with Acute Respiratory Symptoms

Citation for published version (APA): IJzerman, E. P. F. (2009). Progress in diagnostics and prevention of Legionnaires' disease [S.n.

Downloaded from:

Critical Review Form Clinical Prediction or Decision Rule

Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy

Epidemiology of Infectious Complications of H1N1 Influenza Virus Infection

Title: Revision to the Standardized Surveillance and Case Definition for Acute Flaccid Myelitis

Charles Feldman. Charlotte Maxeke Johannesburg Academic Hospital University of the Witwatersrand

Delayed Administration of Antibiotics and Atypical Presentation in Community-Acquired Pneumonia*

PNEUMONIA IN CHILDREN. IAP UG Teaching slides

Anyway I think AA need to improve the paper, particularly on statistical analysis.

MAJOR ARTICLE. Beatriz Rosón, 1 Jordi Carratalà, 1 Jordi Dorca, 2 Aurora Casanova, 3 Frederic Manresa, 2 and Francesc Gudiol 1

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?

Blood cultures in ED. Dr Sebastian Chang MBBS FACEM

Analysis of risk factors for mortality of in-hospital pneumonia patients in Bushulo Major Health Center, Hawassa, Southern Ethiopia

Estimating RSV Disease Burden in the United States

Corporate Medical Policy

Risk of Fractures Following Cataract Surgery in Medicare Beneficiaries

Clinical, radiological and bacteriological profile of patients with community acquired pneumonia (CAP)

Legionnella. You can t t see it but you can catch it. Dr Charmaine Gauci MD, MSc, PhD Head of Disease Surveillance Unit

Application of real-time PCR for the detection of macrolide resistance in Belgian M. pneumoniae strains

Incidence per 100,

Preventing Legionella Transmission An Environmental Health View

Annual Epidemiological Report

UC Irvine Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health

Importance of Atypical Pathogens of Community-Acquired Pneumonia

PCR Is Not Always the Answer

Transcription:

554673SMO0010.1177/2050312114554673SAGE Open MedicineTouray et al. research-article2014 Original Article SAGE Open Medicine Legionella pneumophila cases in a community hospital: A 12-month retrospective review SAGE Open Medicine 2: 2050312114554673 The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalspermissions.nav DOI: 10.1177/2050312114554673 smo.sagepub.com Sunkaru Touray 1,2, Michael C Newstein 1,2, Justin K Lui 1,2, Maureen Harris 2 and Kim Knox 2 Abstract Background: Legionella pneumonia has long been recognized as an important cause of community-acquired pneumonia associated with significant morbidity and mortality; however, the description of the incidence of this disease is restricted to sporadic cases in the literature. With the advent of an inexpensive and rapid urine antigen test, routine testing has become more common. We report findings of a retrospective review of 266 patients who were admitted with a clinical diagnosis of community-acquired pneumonia over a 12-month period and were tested for Legionella pneumophila serogroup 1, reporting the prevalence and determinants of Legionella infection. Methods: Chart reviews of 266 patients admitted for community-acquired pneumonia and who underwent urine antigen testing for Legionella pneumophila during a 1-year time period were conducted, looking at demographic information as well as clinical and laboratory presentation, reporting on the prevalence and determinants of urine antigen positivity using multivariate logistic regression analysis. Results: Legionella pneumophila serogroup 1 was found in 2.3% of cases of community-acquired pneumonia. We also found that altered mental status, diarrhea, history of lung disease, and alcohol intake were significantly associated with pneumonia associated with Legionella. The presence of these four factors had a low sensitivity in predicting Legionella infection (33%); however, they had a positive predictive value of 98%, with a specificity of 100. All the Legionella-infected patients in our study required admission to the intensive care unit, and one of them developed Guillain Barré syndrome, which to our knowledge represents the only reported case of this syndrome related to Legionella infection in an adult in the English scientific literature. Conclusion: Legionella pneumophila serogroup 1 is a common cause of sporadic cases of community-acquired pneumonia associated with a high morbidity and protean manifestations. Clinical features have a poor sensitivity in identifying cases, and routine urine antigen testing in patients with suggestive clinical symptoms appears to be a rational approach in the evaluation of community-acquired pneumonia. Keywords Legionella pneumophila serogroup 1, community-acquired pneumonia, hyponatremia, Legionella urinary antigen test Date received: 2 May 2014; accepted: 28 July 2014 Background Legionella pneumophila is a common cause of communityacquired pneumonia (CAP) and a common cause of outbreaks of hospital-acquired pneumonia. 1 3 Legionella is considered an atypical pulmonary pathogen, along with mycoplasma and chlamydia species. Cases of community-acquired Legionnaires disease are reportedly more severe; however, description of the true incidence of this disease is restricted to sporadic cases in the literature. 2 The clinical presentation of CAP due to Legionella pneumophila overlaps with those of other pathogens. Previous studies have described gastrointestinal and neurologic symptoms, as well as laboratory features such as hyponatremia and hepatic and renal dysfunction as more common in CAP due to Legionella pneumophila; however, these features are nonspecific. 4 6 Because delayed diagnosis and failure to institute appropriate antibiotic coverage have been 1 University of Massachusetts Medical School, Worcester, MA, USA 2 Milford Regional Medical Center, Milford, MA, USA Corresponding author: Sunkaru Touray, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA01655, USA. Email: sunkaru.touray@umassmemorial.org Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).

2 SAGE Open Medicine associated with poor clinical outcomes, 7,8 rapid identification of a causative agent has been an attractive goal. Isolation of Legionella by culture is the ideal means of diagnosis; however, this approach is limited by several factors, including difficulty obtaining sputum samples in patients with non-productive or poorly productive cough, the effects of empiric antibiotic therapy on the yield of sputum samples, and delay in diagnosis as cultures take about 3 5 days to speciate. 9 Currently, diagnosis can be made by urine antigen testing targeting Legionella pneumophila serogroup 1, which has been implicated as the etiology in about 90% of cases. 7,10 This relatively inexpensive enzyme immunoassay has a reported sensitivity that ranges between 76% and 86% for sporadic cases of communityacquired Legionnaires disease and a specificity that approaches 100%. 9,11 We report findings of a retrospective survey of 266 patients who were admitted with a clinical diagnosis of CAP over a 12-month period and were tested for Legionella pneumophila serogroup 1 as a routine laboratory test, reporting the prevalence and determinants of urine antigen positivity in the setting of a pneumonia. Methods Study population This study was conducted at Milford Regional Medical Center (MRMC), a 121-bed community and regional teaching hospital. Retrospective chart reviews of 266 patients admitted from July 2012 to August 2013 with a clinical diagnosis of CAP and a clinical suspicion for Legionella pneumonia who underwent urine antigen testing were conducted. Information gathered included age, sex, reported history of underlying lung disease such as chronic obstructive lung disease (COPD) or asthma, as well as smoking history and a history of alcohol consumption (regardless of quantity). Information on reported symptoms such as diarrhea and confusion was retrieved from patient documentation in electronic medical records as documented in patient s charts by providers. Laboratory data at the time of admission for complete blood count and basic metabolic panel were also collected. All patients underwent testing for Legionella pneumophila serogroup 1 urine antigen using aqualitative rapid assay following manufacturer s instructions (Alere BinaxNOW Legionella Urinary Antigen Card, Waltham, MA, USA). Other data collected included reports on sputum cultures and chest imaging such as radiographs and/or computed tomography. Legionella pneumonia was diagnosed in patients who had clinical features of pneumonia suggested by history and chest imaging; and had a positive urine antigen test. Statisticalanalysis All data were entered into an Epi Info 7.1.2 (Atlanta, GA, USA) data entry form and subsequently exported into STATA version 10 (StataCorp, College Station, TX, USA) for statistical analysis. Stepwise logistic regression was carried out using Legionella pneumophila serogroup 1 antigen positivity as a dependent variable. Independent variables included age, sex, smoking status, alcohol consumption, diarrhea (as documented in the medical records), altered mental status (AMS; defined as confusion, altered sensorium, or coma), presence of an elevated white blood cell (WBC) count greater than 11,000 or a low WBC (less than 4000), season of the year (Winter, Spring, Summer, or Fall), infiltrate on chest imaging (by chest radiograph or computed tomography), and positive sputum cultures for other pathogens. Variables with p value < 0.05 were deemed as significant predictors of Legionella pneumophila serogroup 1 antigen positivity and were retained in our final model. Ethical statement Chart review was done with adherence to our institutional Health Insurance Portability and Accountability Act (HIPAA) regulations. All personal identifiable information such as names, date of birth, medical record numbers, address, or social security numbers on patients included in the study was excluded in the data entry form before exporting to STATA for statistical analysis. Ethics approval was not required for this study as no contact or personal identifiable information was recorded, and all collected data were anonymized. Results Females accounted for 52.3% of participants, while males comprised 47.7%. Baseline characteristics (Table 1) of participants were similar, with a mean age of 71.1 years (95% confidence interval (CI): 69.0 71.2 years) and no statistically significant age difference between the sexes (mean age for females 73.0 years (95% CI: 70.1 75.9 years) vs mean age for males 69.0 years (95% CI: 66.0 71.9 years)). Smoking and the prevalence of reported underlying lung disease were also similar between the sexes. Alcohol use was reported for 12% in men compared to 7% in women, and this difference was statistically significant (χ 2 = 5.69; p = 0.02). Six of the 266 individuals in whom data were obtained during the retrospective review timeframe tested positive for Legionella pneumophila serogroup 1, resulting in a Legionella pneumonia prevalence of 2.3% (95% CI: 0.8% 4.8%). Five of the six individuals who were diagnosed with Legionella pneumonia were male, although this difference was not statistically significant (χ 2 = 3.12; p = 0.078) Five variables were found to be independent predictors of Legionella pneumophila serogroup 1 antigen positivity in our model (Table 2). They are the presence of underlying lung disease, alcohol use, presence of diarrhea, AMS, and age group. The strongest predictors were the presence of

Touray et al. 3 Table 1. Baseline characteristics. Age, years (95% CI) 71.1 (69.0 71.2) Legionella pneumophila Tested Legionella pneumophila 95% CI serogroup 1 prevalence 266 6 (2.3%) 0.8 4.8 Prevalence by sex Tested Legionella pneumophila χ 2 p value Female 139 1 (0.7%) 3.12 0.078 Male 127 5 (3.9%) Age group (years) Tested Legionella pneumophila 15 29 5 0 (0%) 30 44 15 1 (6.7%) 45 59 45 2 (4.4%) 60 69 52 2 (3.9%) 70 79 53 1 (1.9%) 80 96 0 (0%) Smoking Men Women χ 2 p value Never smoked 55/127 (43.3%) 77/139 (55.4%) 4.65 0.098 Current smoker 26/127 (20.5%) 27/139 (19.4%) Former smoker 46/127 (36.2%) 35/139 (25.2%) Alcohol use Men Women χ 2 p value 32/127 (12%) 19/139 (7%) 5.69 0.02 Underlying lung disease* Men Women χ 2 p value 56/127 (44.1%) 49/139 (35.3%) 2.17 0.14 CI: confidence interval. Table 2. Multivariate logistic regression analysis for Legionella pneumonia. Explanatory variables Odds ratio β coefficient 95% CI p value Underlying lung disease (ULD) 8.00 2.08 1.47 43.51 0.016 Alcohol use (EtOH) 8.64 2.16 1.54 48.51 0.014 Reported diarrhea (Diarrhea) 9.63 2.27 1.49 62.39 0.017 Altered mental status (AMS) 9.64 2.27 1.10 84.57 0.041 Age group (Agegp) 0.58 0.55 0.42 0.79 0.001 CI: confidence interval. AMS (odds ratio (OR): 9.64; 95% CI: 1.10 84.57; p = 0.041) and diarrhea (OR: 9.63; 95% CI: 1.49 62.39; p = 0.017). Our model had a low sensitivity, identifying patients with Legionella pneumophila serogroup 1 with a sensitivity of 33.3%; however, it had a high specificity of 100%, the positive predictive value was 100%, and the negative predictive value was 98.5% (Table 3). Sex, smoking history, presence of hyponatremia (sodium less than 130 mmol), season of the year, or positive sputum cultures were not significant predictors of antigen positivity and were therefore excluded from the model. Sputum cultures were positive in 18% of patients, and the common isolates from sputum cultures (in order of frequency) were Staphylococcus aureus (30%), Streptococcus pneumoniae (27.5%), Pseudomonas aeruginosa (12.5%), and Klebsiella pneumoniae (5%). Corynebacterium spp. was isolated in 25% of sputum cultures. Table 3. Sensitivity analysis of multivariate logistic model. Sensitivity 33.3% Specificity 100% Positive predictive value 100% Negative predictive value 98.5% Discussion Our study shows that using routine urine antigen testing, Legionella pneumophila serogroup 1 accounted for a significant number of cases of CAP among hospitalized patients. Our reported prevalence of 2.3% appears to be low on the spectrum of reported prevalence of Legionella pneumonia in the literature. 1,7 The true prevalence could be higher because urine antigen testing has some limitations: first, it has a sensitivity that ranges from 76% to 86%, and, second, it does

4 SAGE Open Medicine not identify other serogroups or non-legionella pneumophila species. Another potential factor inherent in our study design that may explain the relatively low prevalence of infections is that not all patients admitted with CAP were tested. A recent study by Murdoch et al. 12 found a fourfold increase in Legionella cases with the implementation of a routine polymerase chain reaction (PCR) testing strategy, suggesting that many cases will be missed when urine antigen testing is used alone. No cultures were performed on positive specimens, further limiting the ability to detect infected cases. Our results also support the association of some clinical features with Legionella pneumophila, as the observation that the presence of underlying lung disease, alcohol consumption (regardless of quantity), presence of confusion or AMS, and diarrhea are strong predictors of infection (Table 2). When we stratified participants into different age groups (Table 1), there was a higher occurrence among middle-aged participants between 45 and 69 years of age compared to older participants. Furthermore, the odds of Legionella urine antigen positivity were inversely correlated with age group, suggesting a predilection for the younger age group (OR: 0.58; 95% CI: 0.42 0.79). This finding is at variance with reports of Legionella pneumonia among hospitalized patients occurring in older men with underlying diseases. We observed Legionella pneumonia in younger patients, with a trend toward a higher frequency among men, although this difference was not significant. Our observation is consistent with those of a large multicenter study in which Von Baum et al. 7 noted disease occurrence in younger patients, with an equal sex distribution and significantly fewer comorbidities among patients. Some laboratory features such as hyponatremia have been reported to be associated with Legionella pneumophila; however, we failed to replicate this finding as hyponatremia was not associated with urine antigen positivity in multivariate analyses in our study. Indeed, hyponatremia is a nonspecific finding among patients with pneumonia, and it has not been consistently shown to have an association with Legionella pneumophila when compared to those who had pneumonia due to other causes. 13 Studies that found an association were among nosocomial cases and were reported to occur within 5 days of onset of pneumonia. 14 In our study, we only included sodium levels for each participant at the time of admission; hence, we may have found an association if other values in the hospitalization course were included in our analysis. Our observation that alcohol consumption had a strong predictive effect on urine antigen positivity is intriguing because hepatic dysfunction (suggested by elevations in serum transaminases) is one of the reported laboratory derangements associated with Legionella pneumophila. 15,16 Although we did not quantify the amount of alcohol consumed or follow serum transaminases, establishing causality is difficult as we are unable to determine whether hepatic dysfunction is a direct consequence of Legionella pneumophila infection by way of hepatocellular injury or whether the observed elevations in hepatic transaminases are due to alcohol consumption, or both. In sensitivity analysis, our multivariate logistic regression model had a low sensitivity in detecting cases (sensitivity 33%), probably attributed to the relative infrequency and sporadic occurrence of the disease. The multivariate model, however, had a good specificity and could virtually exclude the disease (specificity 100%, negative predictive value 98.5%). The sporadic occurrence of Legionnaires disease as well as the nonspecific clinical and laboratory features demonstrated in studies makes clinical diagnosis a challenge. This is further compounded by the finding that CAP caused by Legionella pneumophila tends to be severe with a trend toward higher mortality. Although none of the six patients diagnosed with Legionella pneumophila in our study died, all of them required admission to the intensive care unit, and four of them (two-thirds) developed respiratory failure requiring intubation and mechanical ventilation. One patient developed Guillain Barré Syndrome (GBS, diagnosed by electromyography) and had a protracted hospitalization. 17 To our knowledge, there have been only two reported cases of Legionella pneumophila causing GBS in the literature, both of which occurred in children. 1,18 One distinguishing feature of our study, as compared to other published studies, is that this was done at one community hospital, whereas other studies tend to be done in tertiary centers, or multicenter studies. Our study has certain limitations: first, not all patients admitted with CAP were tested, and because of the retrospective design of our study, we could not ascertain what influenced physicians decision to order the urine antigen test. The diagnostic test also has some limitations in that it does not detect other Legionella species as well as other serogroups of Legionella pneumophila. Selection bias is also another limitation as the patients who were tested may have been sicker and therefore not representative of all patients in the community. Conclusion Legionella pneumophila is a common cause of CAP among hospitalized patients; its occurrence tends to be sporadic and associated with a high morbidity. Clinical and laboratory features can neither reliably identify cases nor exclude them, and therefore, routine antigen testing among patients hospitalized for severe CAP should be used to promptly identify cases and guide clinicians to tailor antibiotic therapy early on in the hospitalization course. Formerly, when urine antigen testing was deemed expensive, clinical guidelines were in favor of using clinical syndromes to select patients for pathogen-specific diagnostic testing; however, given the availability of a simple and affordable urine antigen test (about US$35 per test), routine testing of severe cases of CAP,

Touray et al. 5 especially among those who develop respiratory failure, appears to be a rational approach. Acknowledgements The authors would like to thank Dr Gail Scully for her valuable input in reviewing this manuscript. We also like to acknowledge the support of Dr William Muller in conducting this research. S.T. and J.K.L. conceived the study and participated in its design and data collection. Data analysis and interpretation were done by S.T. The first draft of the manuscript was written by S.T. and was subsequently reviewed and edited by S.T., J.K.L., M.C.N, M.H., and K.K. All authors approved the final manuscript. Declaration of conflicting interests We declare that we have no competing interests. Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. References 1. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 1990; 69(5): 307 316. 2. Stout JE and Yu VL. Legionellosis. N Engl J Med 1997; 337(10): 682 687. 3. Cabello H, Cortés C, Ruiz M, et al. Community acquired pneumonia. Report of 8 cases of severe pneumonia by serogroup 1 Legionella pneumophila in Chile. Rev Med Chil 2002; 130(3): 309 313. 4. Sharrar RG, Friedman HM, Miller WT, et al. Summertime pneumonias in Philadelphia in 1976. An epidemiologic study. Ann Intern Med 1979; 90(4): 577 580. 5. Tsai TF, Finn DR, Plikaytis BD, et al. Legionnaires disease: clinical features of the epidemic in Philadelphia. Ann Intern Med 1979; 90(4): 509 517. 6. Mulazimoglu L and Yu VL. Can Legionnaires disease be diagnosed by clinical criteria? A critical review. Chest J 2001; 120(4): 1049 1053. 7. Von Baum H, Ewig S, Marre R, et al. Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia. Clin Infect Dis 2008; 46(9): 1356 1364. 8. Pedro-Botet ML, Stout J and Yu V. Clinical manifestations and diagnosis of Legionella infection. UpToDate, 2013, http:// www.uptodate.com/contents/clinical-manifestations-anddiagnosis-of-legionella-infection?detectedlanguage=en&;so urce=search_result&search=legionella+pneumonia&selected Title=1~23&provider=noProvider#H4 9. Kazandjian D, Chiew R and Gilbert GL. Rapid diagnosis of Legionella pneumophila serogroup 1 infection with the Binax enzyme immunoassay urinary antigen test. J Clin Microbiol 1997; 35(4): 954 956. 10. Yu VL, Plouffe JF, Pastoris MC, et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis 2002; 186(1): 127 128. 11. Helbig JH, Uldum SA, Bernander S, et al. Clinical utility of urinary antigen detection for diagnosis of communityacquired, travel-associated, and nosocomial Legionnaires disease. J Clin Microbiol 2003; 41(2): 838 840. 12. Murdoch DR, Podmore RG, Anderson TP, et al. Impact of routine systematic polymerase chain reaction testing on case finding for Legionnaires disease: a pre-post comparison study. Clin Infect Dis 2013; 57(9): 1275 1281. 13. Cunha BA. Severe Legionella pneumonia: rapid presumptive clinical diagnosis with Winthrop-University Hospital s weighted point score system (modified). Heart Lung 2008; 37(4): 311 320. 14. Yu VL, Kroboth FJ, Shonnard J, et al. Legionnaires disease: new clinical perspective from a prospective pneumonia study. Am J Med 1982; 73(3): 357 361. 15. Falcó V, Fernández de Sevilla T, Alegre J, et al. Legionella pneumophila. A cause of severe community-acquired pneumonia. Chest 1991; 100(4): 1007 1011. 16. Cunha BA. Legionnaires disease: clinical differentiation from typical and other atypical pneumonias. Infect Dis Clin North Am 2010; 24(1): 73 105. 17. Lui JK, Touray S, Tosches WA, Richard K. Acute inflammatory demyelinating polyradiculopathy in Legionella pneumonia. Muscle Nerve. 2014 Jul 15. 18. Akyildiz B, Gümüs H, Kumandas S, et al. Guillain-Barré syndrome associated with Legionnella infection. J Trop Pediatr 2008; 54(4): 275 277. 19. Canpolat M, Kumandas S, Yikilmaz A, et al. Transverse myelitis and acute motor sensory axonal neuropathy due to Legionella pneumophila: a case report. Pediatr Int 2013; 55(6): 778 782.